about
sameAs
Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in ThailandDiscontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study.Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.Influence of body weight on achieving indinavir concentrations within its therapeutic window in HIV-infected Thai patients receiving indinavir boosted with ritonavir.Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum.Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults With Moderate Renal Function ImpairmentPregnancy outcomes among HIV-infected women undergoing antiretroviral therapy.Histoplasmosis and penicilliosis among HIV-infected Thai patients: a retrospective review.Long term outcomes of nevirapine containing antiretroviral therapy at a center in Thailand.The efficacy and adverse effects of GPO-VIR (stavudine+lamivudine+nevirapine) in treatment-naïve adult HIV patients.Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand.Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial.New-Onset Diabetes and Antiretroviral Treatments in HIV-Infected Adults in Thailand.
P50
Q28535141-BFBAB47B-10C4-49E7-A047-FE142B763AB8Q34196792-9D2DAF5B-3358-4D93-B002-3E71BB3A8DA5Q34332659-EB540644-A359-4E2B-A79E-508A02B7B24AQ34677780-7D120810-A283-408D-8F07-872D97AFA620Q35784583-BE891918-C064-4E92-AF6F-B0A10C9923A1Q36167503-A61513EE-9218-41FD-9A53-F53FBF6D2B94Q37225457-D81D8AD5-94BE-4CE8-8C6A-E588B06CE16DQ38053433-5EB99B47-BCA8-4F3C-83D5-5391013C9F52Q39081824-79736DC1-ABCC-487A-9B15-5A4692E66CC6Q39525270-59CF34B7-5654-4CFB-83B4-7C02513AEA51Q39591265-E01BF330-D11B-493C-965D-1D62157ABC34Q40596041-1B785D31-F8F4-408E-9BDE-87C79F94413BQ41319439-BED49BA7-6617-4180-BD9B-909D4973E96A
P50
description
onderzoeker
@nl
name
Chureeratana Bowonwatanuwong
@ast
Chureeratana Bowonwatanuwong
@en
Chureeratana Bowonwatanuwong
@es
Chureeratana Bowonwatanuwong
@sl
type
label
Chureeratana Bowonwatanuwong
@ast
Chureeratana Bowonwatanuwong
@en
Chureeratana Bowonwatanuwong
@es
Chureeratana Bowonwatanuwong
@sl
prefLabel
Chureeratana Bowonwatanuwong
@ast
Chureeratana Bowonwatanuwong
@en
Chureeratana Bowonwatanuwong
@es
Chureeratana Bowonwatanuwong
@sl